Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Associated Press - Monday, Oct. 29, 2001
Randolph E. Schmid, Associated Press Writer
The drug blocks reproduction of the virus, the agency said. Its technical name is tenofovir disoproxil fumarate.
AIDS survival rates have increased in recent years as combinations of drugs are used to battle the virus.
FDA noted that the virus mutates rapidly, however, and often develops resistance to drugs. That makes development of new medications necessary. The FDA said it approved the new pill after two clinical trials on more than 700 people who showed increased HIV despite treatment with other drugs. They showed significant reductions in the amount of HIV in their blood during the trials, the agency said.
The new drug is taken as a single pill once a day. Supplies should be available by the end of this week, according to the manufacturer, Gilead Sciences of Foster City, Calif.
Gilead spokeswoman Amy Flood said a year's supply of Viread would cost $4,135, but added that much of that probably would be covered by insurance.
In clinical trials the most common side effects of Viread were moderate diarrhea, nausea, vomiting and flatulence. Viread is a type of drug known as a nucleotide analog. Its action is similar to nucleoside analogs, which the FDA said have been connected to some serious liver conditions. --- On the Net: Food and Drug Administration: http://www.fda.gov
011029
AP011017
Copyright © 2001 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .